|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q3 FY2022
As of Sep 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||||
| Cash and due from banks | |||||||||||||||
| Restricted cash (amounts related to VIEs of $6.3 million and $6.3 million, respectively) | |||||||||||||||
| Interest bearing deposits in banks | |||||||||||||||
| Total cash and cash equivalents | |||||||||||||||
| Debt securities available-for-sale, at fair value | |||||||||||||||
| Loans held for sale, at fair value | |||||||||||||||
| Loans held for sale, at LCM | |||||||||||||||
| Loans held for investment, at fair value | |||||||||||||||
| Loans held for investment, at amortized cost, net of deferred fees and costs | |||||||||||||||
| Allowance for credit losses | |||||||||||||||
| Loans held for investment, at amortized cost, net | |||||||||||||||
| Federal Home Loan Bank and Federal Reserve Bank stock | |||||||||||||||
| Settlement receivable | |||||||||||||||
| Residuals in securitizations, at fair value | |||||||||||||||
| Investments | |||||||||||||||
| Joint Ventures | |||||||||||||||
| Controlled Investments | |||||||||||||||
| Non-Control Investments | |||||||||||||||
| Joint Ventures and Other Investments | |||||||||||||||
| Total investments | |||||||||||||||
| Goodwill and intangibles | |||||||||||||||
| Right of use assets | |||||||||||||||
| Derivative instruments | |||||||||||||||
| Deferred tax asset, net | |||||||||||||||
| Servicing assets | |||||||||||||||
| Servicing assets, at fair value | |||||||||||||||
| Servicing assets, at LCM | |||||||||||||||
| Total servicing assets | |||||||||||||||
| Other assets | |||||||||||||||
| Assets held for sale | |||||||||||||||
| Total assets | |||||||||||||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | |||||||||||||||
| Liabilities: | |||||||||||||||
| Deposits: | |||||||||||||||
| Noninterest-bearing | |||||||||||||||
| Interest-bearing | |||||||||||||||
| Total deposits | |||||||||||||||
| Borrowings (including borrowings of VIEs of $105.1 million and $127.1 million, respectively) | |||||||||||||||
| Derivative instruments | |||||||||||||||
| Dividends payable | |||||||||||||||
| Lease liabilities | |||||||||||||||
| Deferred tax liabilities, net | |||||||||||||||
| Due to participants | |||||||||||||||
| Accounts payable, accrued expenses and other liabilities | |||||||||||||||
| Liabilities directly associated with assets held for sale | |||||||||||||||
| Total liabilities | |||||||||||||||
| Shareholders' Equity: | |||||||||||||||
| Preferred stock | |||||||||||||||
| Series A Preferred stock | |||||||||||||||
| Series B Preferred stock | |||||||||||||||
| Total preferred stock | |||||||||||||||
| Common stock (par value $0.02 per share; 199,946 authorized, 28,899 and 28,658 issued and outstanding, respectively) | |||||||||||||||
| Retained earnings | |||||||||||||||
| Additional paid-in capital | |||||||||||||||
| Accumulated other comprehensive loss, net of income taxes | |||||||||||||||
| Total shareholders' equity | |||||||||||||||
| Total liabilities and shareholders' equity | |||||||||||||||
Loading...
